Veteran drug policy reformer Matt Bowden suggested certain synthetic cannabinoids should be explored as substitute drugs in Fentanyl crisis, and corrected misinformation that his company had invented synthetic cannabinoid 5f-pb-22 which caused 4 deaths in USA.